1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > The United States Market for In Vitro Diagnostic Tests

The United States Market for In Vitro Diagnostic Tests

  • March 2014
  • -
  • Kalorama Information
  • -
  • 130 pages

The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market. Most recently the U.S. IVD market weathered interrupted lab and healthcare sector investment in anticipation of the Affordable Care Act and several regulatory and austerity measures on the part of government payers that constricted payments for clinical testing.

In this report, The United States Market for In Vitro Diagnostic Tests, Kalorama Information analyst Emil Salazar takes a considered look into these trends and what they mean for diagnostic manufacturers and investors.

As the report notes, there are both challenging developments and postiive trends which make the United States a stable IVD market: The expansion of the insured population under the ACA; demographic aging that increases demand for clinical testing and a medical program that serves as a leading, stable vehicle for payment (Medicare); relatively optimistic macroeconomic indicators vis-à-vis the domestic outlook five years ago or other developed markets in the world; and continued product innovation and industry responsiveness to clients’ needs in the world’s largest IVD market.

This report includes important tools for business planners, including market size estimates and forecasts for the following IVD segments:

Point of Care (Glucose, Professional, OTC)
Histology and Cytology
Clinical Chemistry
Immunoassays (Infectious Disease, Non-Infectious Disease)
Molecular Assays (Non-Infectious Disease)
Hematology
Urinalysis
Flow Cytometry
Coagulation
Microbiology and Virology (ID/AST, Molecular)
Blood Testing
Market sizes, forecasts and shares are provided, as well as a geographic breakdown of the segments, where possible. Changes in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Current market numbers are presented for 2011, with projections given through 2016.

The following data points are included in this report:

U.S. Health Expenditure
U.S. Clinical Lab Expenditure
U.S. Infectious Disease Market Opportunities
Affordable Care Act (ACA)
Clinical Testing under Medicare – Reimbursement Cuts and “Revaluation”
Molecular Diagnostics and Medicare Policy
Patient Population
Healthcare System Utilization
Aging
Disease Prevalence and Incidence
Analyst Conclusions About the Market

Many of the top IVD companies use Kalorama Information products for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. This edition greatly expands coverage of the field and tracks the most important developments. See aspects of the industry that might not be available in your company's internal resources. View the market from an independent point of view. Learn about competitors in away that may be invisible to internal personnel. Know the market players - your competitors and potential partners, in proper context and classification. Save countless hours of staff time and other research expenses with the authoritative guide for IVD market estimates and forecasts.

Table Of Contents

The United States Market for In Vitro Diagnostic Tests

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Point of Care Diagnostics, BCC Research

Point of Care Diagnostics, BCC Research

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Review business opportunities in the thriving near-patient testing market. - Learn about the impact of chronic diseases, growing and aging populations. - Receive information about ...

2016 World In Vitro Diagnostic Instrumentation Review

2016 World In Vitro Diagnostic Instrumentation Review

  • $ 6500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com reviews operating characteristics and features of major automated and semi-automated high-, medium-, and low-volume/POC in vitro diagnostic systems within the ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.